His
undergraduate education was at UC
Berkeley (elected to Phi Beta Kappa
as a junior), medical school (Regents
Scholar; elected to Alpha Omega Alpha,
the medical honor society, as a junior)
and internal medicine residency at
UC San Francisco, and initial lipid
research at the National Heart, Lung
and Blood Institute at the National
Institutes of Health (NIH) as a Staff
Associate in the intramural (Molecular
Diseases Branch/Lipid Metabolism Branch)
and Science Project Officer in the
extramural (Cardiac Diseases Branch;
Division of Heart and Vascular Diseases)
divisions. He subsequently was on
faculty jointly in both the Department
of Cardiology and the Department of
Thoracic and Cardiovascular Surgery
at Cedars-Sinai Medical Center where
he was a sub-investigator on a large
NIH Specialized Center of Research
Program Project Grant. He founded
and directs the Ventura Heart Institute,
which conducts education, research
(he was a Principal Investigator in
over 160 clinical trials in new and
novel therapies for dyslipidemias
(most recently focused on PCSK9 monoclonal
antibodies and CETP inhibitors), heart
failure, hypertension, anti-arrhythmics
and devices), as well as in information
technology and preventive cardiovascular
programs. He was the principal
investigator for cardiovascular clinical
trials with Westlake Medical Research
and is now lead principal investigator
for a developing clinical research
consortium. In 1987, Dr. Loh
created and has continued to refine
a unique electronic medical record
system that allows him to care for
his patients and provide key data
to colleagues or emergency facilities
anywhere and anytime. In 2001,
he was the recipient of one of four
international grants from the London-based
Future Forum on innovative preventive
cardiology strategies; his grant focused
on innovative use of information technology
to improve quality of care and outcome.
He
chaired the HCA Los Robles Hospital
and Medical Center's Institutional
Review Board for 18 years, founded
the Bioethics Committee serving as
its chair for 3 years, and directed
the echocardiography laboratory for
15 years. He has been a member of
Amgen’s Institutional BioSafety Committee,
the State of California Department
of Health Services Cardiovascular
Disease Prevention Coalition, the
manuscript review board and ad hoc
editor for the Journal of Clinical
Outcomes Management, the Expert Panel
on Outcomes Evaluation and Research
for the American Heart Association,
and an advisor to the Advisory Board
Company/Cardiology Preeminence Roundtable
based in Washington DC. He served
as an Executive Steering Committee
member of the West Lipid Association
Board of Directors. He is a member
of the Vascular Biology Working Group,
the Future Forum and the Mobile Healthcare
Alliance. He has served as the cardiovascular
consultant for the SportsMed Company/Sports
Club of America, and was appointed
to the State of California Health
Executive Advisory Review Team to
consult on preventive cardiology,
and to the Information Systems subcommittee
of The Healthcare Collaborative at
UCLA. He was appointed to the Lumetra,
formerly known as CMRI (California’s
Medicare Quality Improvement Organization),
Expert Panel on Acute Myocardial Infarction
for hospital quality improvement.
He served as the first Chief of Medicine
for the Thousand Oaks Surgical Hospital.
From 2007 to 2009, Dr. Loh
was Program Director for Cardiovascular
Services for the Community Memorial
Health System based in Ventura, CA,
assisting them in the development
of a comprehensive heart and vascular
clinical program. He was a Consultant
Physician for the Ventura County Health
Care Agency, focusing on disease management
and enhanced development of clinical
research programs. He is a
charter member of Lipidologists of
Los Angeles, and a member of the Medical
Advisory Boards for Doximity™,
Tiatros™, Skipta (medical social
network), Genomic Express, DoctorBase™
and a member of HealthTap™ ClubMD
as well as a Founding Medical Expert
and Chief Scholar. He was the
lead ambassador for Sermo's Cardiology
Hub. He is director of cardiovascular
services for MOREHealth, a telehealth
company servicing patients and healthcare
providers in China, focused on oncology
but developing cardiovascular capabilities.
He is past chair of the Technology
and Innovation Committee of the California
Chapter of the American College of
Cardiology, and is on the chapter's
Board of Directors. He is Co-Founder
and Chief Medical Officer for Infermedica,
an artificial intelligence company
focused on clinical decision support,
and Chief Medical Advisor for Confideo
Labs/DoctorVirtualis, a healthcare
technology company exploring innovative
applications of virtual reality in
healthcare. He serves on two Artificial
Intelligence for Health Topic Groups
(Symptom Assessment and Clinical Evaluation)
for the International Telecommunication
Union of the World Health Organization.
He is also a member of the Global
Panel for MIT Technology Review.
In
1993, he was appointed to two White
House Briefing Teams (Budget and Finance,
and Provider Choice, serving as that
team's facilator) for the President’s
healthcare reform proposal and served
on the Executive Steering Committee
of the National Health Policy Council,
a bipartisan non-profit foundation
chaired by Sen. Jay Rockefeller IV.
He was a surrogate speaker for the
White House on health care reform,
lecturing nationally and regionally
as well as providing interviews for
newspapers, radio and television programs.
He has served as a healthcare advisor
for the presidential campaigns of
retired General Wesley Clark, former
Senator John Edwards and was a member
of then Senator Obama's Healthcare
Advisory Committee.
He
has published in the medical literature
and provided numerous articles, op-eds
and interviews for magazines, newspapers,
radio, and television including segments
in New York with NBC’s Today
show on premature heart disease and
ABC’s HOME SHOW on health care
reform. He writes a health column,
Second Opinion, for the Star newspapers
(copies of which are accessible from
the top menus of these web pages,
with the most recent columns accessible
by searching "Irving Loh"
at www.vcstar.com).
Lecture topics include: cardiovascular
risk reduction and integrated disease
management strategies for the primary
and secondary prevention of heart
disease, the disease management of
congestive heart failure, dyslipidemias,
hypertension, cardiac complications
of COVID-19, and the use of medical
information technology including artificial
intelligence to optimize quality and
outcome in high risk and high cost
patients. A link
to his healthcare information technology
lecture at UC Berkeley for the
Center for Information Technology
Research in the Interest of Society
(CITRIS) and the School of Public
Health is available by clicking the
link on the home page or by searching
on YouTube™.
He was an invited presenter to the
Inaugural Harvard America China Health
Summit in Boston in 2011 on the topic
of healthcare information technology
to improve quality of care and patient
outcome. He has conducted primers
for colleagues on computer presentations
at regional and national speaker bureaus.
He has delivered over 500 lectures,
keynotes, presentations, abstracts
and webcasts. He also presented
at a TEDx program (http://youtu.be/b51KhIy3cA0)
on how medical knowledge advances
through the use of rigorously conducted
clinical trials.
And wonderful news
for me and my patients is that my
prior MA, Margarita, has joined me
to care for my patients. She
can be reached at [email protected]
or 805.405.2082
|
